PATH is a leading global organization dedicated to accelerating the development and delivery of innovative solutions to tackle the world's most pressing health challenges. With a specific focus on malaria, PATH's Malaria Vaccine Initiative is actively involved in the research, development, and implementation of vaccines to combat this deadly disease. They work closely with partners and stakeholders to ensure the availability and affordability of malaria vaccines, aiming to protect children at risk and reduce the burden of malaria worldwide.
PATH's Malaria Vaccine Initiative has played a pivotal role in the introduction and expansion of the first malaria vaccine, RTS,S, recommended by the World Health Organization. Their efforts have contributed to the phased rollout of the vaccine in various African countries, including Kenya, Ghana, and Malawi. By advocating for broader vaccine use, conducting research, and supporting policy and regulatory pathways, PATH is actively working towards the goal of controlling and ultimately eradicating malaria.
Generated from the website